Abundance Wealth Counselors Increases Stock Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Abundance Wealth Counselors increased its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 38.8% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 14,739 shares of the pharmacy operator’s stock after purchasing an additional 4,118 shares during the quarter. Abundance Wealth Counselors’ holdings in Walgreens Boots Alliance were worth $320,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also made changes to their positions in the company. Fulton Bank N.A. raised its position in shares of Walgreens Boots Alliance by 0.5% in the fourth quarter. Fulton Bank N.A. now owns 107,071 shares of the pharmacy operator’s stock valued at $2,796,000 after purchasing an additional 523 shares during the period. Insight Folios Inc raised its position in shares of Walgreens Boots Alliance by 5.8% in the fourth quarter. Insight Folios Inc now owns 9,640 shares of the pharmacy operator’s stock valued at $252,000 after purchasing an additional 525 shares during the period. Atlas Brown Inc. raised its position in shares of Walgreens Boots Alliance by 1.8% in the first quarter. Atlas Brown Inc. now owns 31,593 shares of the pharmacy operator’s stock valued at $685,000 after purchasing an additional 550 shares during the period. Pinnacle Financial Partners Inc raised its position in shares of Walgreens Boots Alliance by 4.9% in the fourth quarter. Pinnacle Financial Partners Inc now owns 11,866 shares of the pharmacy operator’s stock valued at $310,000 after purchasing an additional 555 shares during the period. Finally, Westpac Banking Corp raised its position in shares of Walgreens Boots Alliance by 10.1% in the fourth quarter. Westpac Banking Corp now owns 6,100 shares of the pharmacy operator’s stock valued at $159,000 after purchasing an additional 560 shares during the period. 58.59% of the stock is currently owned by hedge funds and other institutional investors.

Walgreens Boots Alliance Stock Performance

WBA opened at $11.10 on Thursday. Walgreens Boots Alliance, Inc. has a fifty-two week low of $11.10 and a fifty-two week high of $31.32. The company has a current ratio of 0.65, a quick ratio of 0.31 and a debt-to-equity ratio of 0.49. The firm’s fifty day moving average price is $16.23 and its two-hundred day moving average price is $19.95.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Thursday, June 27th. The pharmacy operator reported $0.63 earnings per share for the quarter, missing analysts’ consensus estimates of $0.68 by ($0.05). Walgreens Boots Alliance had a positive return on equity of 12.63% and a negative net margin of 3.99%. The business had revenue of $36.40 billion for the quarter, compared to analyst estimates of $35.94 billion. During the same quarter in the prior year, the firm earned $1.00 EPS. The firm’s quarterly revenue was up 2.8% on a year-over-year basis. On average, equities analysts anticipate that Walgreens Boots Alliance, Inc. will post 2.87 EPS for the current year.

Walgreens Boots Alliance Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, June 12th. Shareholders of record on Tuesday, May 21st were issued a dividend of $0.25 per share. The ex-dividend date of this dividend was Monday, May 20th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 9.01%. Walgreens Boots Alliance’s payout ratio is presently -14.84%.

Insider Buying and Selling at Walgreens Boots Alliance

In related news, Director Inderpal S. Bhandari acquired 3,000 shares of the business’s stock in a transaction on Thursday, April 11th. The stock was bought at an average cost of $18.05 per share, with a total value of $54,150.00. Following the completion of the acquisition, the director now owns 3,000 shares in the company, valued at $54,150. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Company insiders own 17.40% of the company’s stock.

Analyst Ratings Changes

A number of research firms have recently commented on WBA. Bank of America reissued an “underperform” rating and issued a $11.00 price target (down previously from $22.00) on shares of Walgreens Boots Alliance in a research report on Friday, June 28th. JPMorgan Chase & Co. dropped their price target on shares of Walgreens Boots Alliance from $30.00 to $20.00 and set an “overweight” rating on the stock in a research report on Monday. Morgan Stanley lowered their price objective on shares of Walgreens Boots Alliance from $13.00 to $9.00 and set an “underweight” rating on the stock in a research note on Friday, June 28th. SVB Leerink lowered their price objective on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set a “market perform” rating on the stock in a research note on Monday, March 18th. Finally, UBS Group lowered their price objective on shares of Walgreens Boots Alliance from $17.00 to $12.00 and set a “neutral” rating on the stock in a research note on Wednesday. Four investment analysts have rated the stock with a sell rating, eleven have given a hold rating and two have issued a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Hold” and an average target price of $17.71.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.